Your browser doesn't support javascript.
loading
Prediction of acute myeloid leukaemia risk in healthy individuals.
Abelson, Sagi; Collord, Grace; Ng, Stanley W K; Weissbrod, Omer; Mendelson Cohen, Netta; Niemeyer, Elisabeth; Barda, Noam; Zuzarte, Philip C; Heisler, Lawrence; Sundaravadanam, Yogi; Luben, Robert; Hayat, Shabina; Wang, Ting Ting; Zhao, Zhen; Cirlan, Iulia; Pugh, Trevor J; Soave, David; Ng, Karen; Latimer, Calli; Hardy, Claire; Raine, Keiran; Jones, David; Hoult, Diana; Britten, Abigail; McPherson, John D; Johansson, Mattias; Mbabaali, Faridah; Eagles, Jenna; Miller, Jessica K; Pasternack, Danielle; Timms, Lee; Krzyzanowski, Paul; Awadalla, Philip; Costa, Rui; Segal, Eran; Bratman, Scott V; Beer, Philip; Behjati, Sam; Martincorena, Inigo; Wang, Jean C Y; Bowles, Kristian M; Quirós, J Ramón; Karakatsani, Anna; La Vecchia, Carlo; Trichopoulou, Antonia; Salamanca-Fernández, Elena; Huerta, José M; Barricarte, Aurelio; Travis, Ruth C; Tumino, Rosario.
Affiliation
  • Abelson S; Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.
  • Collord G; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Ng SWK; Department of Paediatrics, University of Cambridge, Cambridge, UK.
  • Weissbrod O; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
  • Mendelson Cohen N; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
  • Niemeyer E; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
  • Barda N; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Zuzarte PC; Clalit Research Institute, Tel Aviv, Israel.
  • Heisler L; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Sundaravadanam Y; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Luben R; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Hayat S; Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Wang TT; Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Zhao Z; Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.
  • Cirlan I; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Pugh TJ; Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.
  • Soave D; Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.
  • Ng K; Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.
  • Latimer C; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Hardy C; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Raine K; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Jones D; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Hoult D; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Britten A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • McPherson JD; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Johansson M; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Mbabaali F; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
  • Eagles J; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
  • Miller JK; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Pasternack D; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Timms L; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Krzyzanowski P; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Awadalla P; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Costa R; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Segal E; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Bratman SV; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Beer P; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Behjati S; European Molecular Biology Laboratory, European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton, UK.
  • Martincorena I; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
  • Wang JCY; Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.
  • Bowles KM; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Quirós JR; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Karakatsani A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • La Vecchia C; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Trichopoulou A; Department of Paediatrics, University of Cambridge, Cambridge, UK.
  • Salamanca-Fernández E; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Huerta JM; Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada.
  • Barricarte A; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Travis RC; Division of Medical Oncology and Hematology, University Health Network, Toronto, Ontario, Canada.
  • Tumino R; Department of Molecular Haematology, Norwich Medical School, The University of East Anglia, Norwich, UK.
Nature ; 559(7714): 400-404, 2018 07.
Article in En | MEDLINE | ID: mdl-29988082
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Health / Genetic Predisposition to Disease / Mutation Type of study: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Nature Year: 2018 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Health / Genetic Predisposition to Disease / Mutation Type of study: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Nature Year: 2018 Document type: Article Affiliation country: